COVID-19与肺癌：从爆发到康复的全面概述
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery.
作者信息
Bungaro Maristella, Passiglia Francesco, Scagliotti Giorgio V
机构信息
Department of Oncology, University of Turin, San Luigi Hospital, 10043 Orbassano, Italy.
出版信息
Biomedicines. 2022 Mar 26;10(4):776. doi: 10.3390/biomedicines10040776.
Abstract
Lung cancer patients have been associated with an increased risk of COVID-19 infection, pulmonary complications, and worse survival outcomes compared to the general population. The world's leading professional organizations provided new recommendations for the diagnosis, treatment, and follow-up of lung cancer patients during the pandemic as a guide for prioritizing cancer care issues. Telemedicine was preferred for non-urgent consultations, and screening programs were temporarily suspended, leading to possible diagnostic delays along with an estimated increase in cause-specific mortality. A vaccine campaign has recently emerged as the main weapon to fight the COVID-19 pandemic, inverting this negative trend. This work aims to provide a comprehensive overview of the epidemiology and immune-pathophysiology of SARS-CoV-2 infection in cancer patients, highlighting the most relevant changes in the clinical management of lung cancer patients during the pandemic.
摘要
与普通人群相比，肺癌患者感染新冠病毒、出现肺部并发症及生存结局较差的风险更高。全球主要专业组织针对大流行期间肺癌患者的诊断、治疗及随访提供了新建议，作为优先处理癌症护理问题的指导。非紧急会诊首选远程医疗，筛查项目暂时中止，这可能导致诊断延迟，并估计特定病因死亡率会上升。最近，疫苗接种运动已成为抗击新冠疫情的主要武器，扭转了这一消极趋势。这项工作旨在全面概述癌症患者中新冠病毒感染的流行病学和免疫病理生理学，突出大流行期间肺癌患者临床管理中最相关的变化。
相似文献
1
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery.COVID-19与肺癌：从爆发到康复的全面概述
Biomedicines. 2022 Mar 26;10(4):776. doi: 10.3390/biomedicines10040776.
2
A Reminder of Skin Cancer During the COVID-19 Pandemic.新冠疫情期间对皮肤癌的提醒。
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
3
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.《COVID-19 大流行对英国英格兰因诊断延误导致的癌症死亡人数的影响：一项全国性基于人群的建模研究》。
Lancet Oncol. 2020 Aug;21(8):1023-1034. doi: 10.1016/S1470-2045(20)30388-0. Epub 2020 Jul 20.
4
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
5
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
6
[BREAST CANCER COMPLICATIONS DURING THE COVID-19 PANDEMIC - LESSONS LEARNT].
Harefuah. 2022 Feb;161(2):101-103.
7
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用：恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
8
Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues.2019冠状病毒病大流行期间肺癌治疗的叙述性综述：陷阱与问题
Transl Lung Cancer Res. 2021 Jan;10(1):475-482. doi: 10.21037/tlcr-20-640.
9
Return-to-work, disabilities and occupational health in the age of COVID-19.新冠疫情时代的重返工作岗位、残疾与职业健康。
Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18.
10
COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges.新型冠状病毒肺炎与肺癌：最新筛查、诊断、治疗及挑战。
J Int Med Res. 2022 Sep;50(9):3000605221125047. doi: 10.1177/03000605221125047.
引用本文的文献
1
Lung Cancer Under Siege in Spain: Timeliness, Treatment, and Survival Before and After the COVID-19 Pandemic.西班牙肺癌形势严峻：新冠疫情前后的及时性、治疗与生存情况
Cancers (Basel). 2025 Aug 14;17(16):2655. doi: 10.3390/cancers17162655.
2
The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.2019年冠状病毒病疫情对癌症护理服务延误和中断的全球影响：一项系统综述和荟萃分析
Nat Cancer. 2025 Jan;6(1):194-204. doi: 10.1038/s43018-024-00880-4. Epub 2025 Jan 2.
3
Insights into cancer characteristics among SARS-CoV-2 infected hospitalized patients: a comprehensive analysis from the National Clinical Registry for COVID-19.SARS-CoV-2 感染住院患者的癌症特征分析：来自 COVID-19 国家临床注册中心的综合分析。
J Cancer Res Clin Oncol. 2024 Nov 15;150(11):500. doi: 10.1007/s00432-024-05966-1.
4
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes.胸部恶性肿瘤患者新冠病毒疫苗接种的前瞻性观察研究：不良事件、突破性感染和生存结果
Biomedicines. 2024 Feb 27;12(3):535. doi: 10.3390/biomedicines12030535.
5
Coronavirus disease 2019 and lung cancer: where are we?2019冠状病毒病与肺癌：我们目前的情况如何？
Explor Target Antitumor Ther. 2023;4(5):1082-1094. doi: 10.37349/etat.2023.00182. Epub 2023 Oct 30.
6
Patient Report on the Impact of Coronavirus Disease 2019 and Living With Lung Cancer.2019年冠状病毒病及肺癌共存对患者的影响报告
JTO Clin Res Rep. 2023 Jul 16;4(9):100549. doi: 10.1016/j.jtocrr.2023.100549. eCollection 2023 Sep.
7
Detection of SARS-CoV-2 RNA by In Situ Hybridization in Lung-Cancer Cells Metastatic to Brain and in Adjacent Brain Parenchyma.通过原位杂交检测转移至脑的肺癌细胞及邻近脑实质中的SARS-CoV-2 RNA。
Pathogens. 2023 May 29;12(6):772. doi: 10.3390/pathogens12060772.
8
Outcomes of Thoracoscopic Lobectomy after Recent COVID-19 Infection.近期感染新型冠状病毒肺炎后胸腔镜肺叶切除术的结果
Pathogens. 2023 Feb 5;12(2):257. doi: 10.3390/pathogens12020257.
9
An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York.美国新泽西州、宾夕法尼亚州和纽约州的 COVID-19 疫苗分配情况研究
Int J Environ Res Public Health. 2022 Nov 24;19(23):15629. doi: 10.3390/ijerph192315629.
本文引用的文献
1
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center.在新冠疫情期间开展肿瘤手术：来自一家意大利癌症中心的情况
Explor Target Antitumor Ther. 2021;2(5):481-489. doi: 10.37349/etat.2021.00058. Epub 2021 Oct 31.
2
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort.癌症合并 SARS-CoV-2 感染患者结局的决定因素：古斯塔夫·鲁西队列研究结果。
Nat Cancer. 2020 Oct;1(10):965-975. doi: 10.1038/s43018-020-00120-5. Epub 2020 Sep 22.
3
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.严重急性呼吸综合征冠状病毒 2 疫苗在胸部癌症患者中的疗效：一项支持在两剂疫苗接种后血清学应答轻微的患者中接种第三剂疫苗的前瞻性研究。
J Thorac Oncol. 2022 Feb;17(2):239-251. doi: 10.1016/j.jtho.2021.10.015. Epub 2021 Nov 16.
4
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.肺癌与严重急性呼吸综合征冠状病毒 2 感染：确定重要的研究知识空白。
J Thorac Oncol. 2022 Feb;17(2):214-227. doi: 10.1016/j.jtho.2021.11.001. Epub 2021 Nov 10.
5
Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis.癌症患者在进行全身性抗癌治疗期间感染新型冠状病毒肺炎的结局。单机构经验。一项回顾性分析。
Contemp Oncol (Pozn). 2021;25(3):147-152. doi: 10.5114/wo.2021.109362. Epub 2021 Sep 21.
6
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy.COVID-19 疫苗在接受积极治疗的实体瘤成年癌症患者中的应用：血清阳性率和安全性。意大利的一项前瞻性观察研究。
Eur J Cancer. 2021 Nov;157:441-449. doi: 10.1016/j.ejca.2021.08.035. Epub 2021 Sep 2.
7
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.早期 IFN-α 特征和持续功能障碍是严重 COVID-19 中 NK 细胞的显著特征。
Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002. Epub 2021 Sep 4.
8
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group.癌症患者对SARS-CoV-2疫苗的反应（ReCOVer研究）：希腊合作肿瘤学组的一项前瞻性队列研究
Cancers (Basel). 2021 Sep 15;13(18):4621. doi: 10.3390/cancers13184621.
9
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors.BNT162b2疫苗在实体瘤癌症患者中的六个月疗效和毒性情况
Cancer Discov. 2021 Oct;11(10):2430-2435. doi: 10.1158/2159-8290.CD-21-1072. Epub 2021 Sep 2.
10
Lung Fibrosis after COVID-19: Treatment Prospects.新冠病毒感染后肺纤维化：治疗前景
Pharmaceuticals (Basel). 2021 Aug 17;14(8):807. doi: 10.3390/ph14080807.
Zotero 插件